| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.125 | 0 | 0 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.921 | 2.010 |
| Total Income - EUR | 1.125 | 0 | 0 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.921 | 2.010 |
| Total Expenses - EUR | 927 | 244 | 762 | 2.888 | 2.844 | 971 | 953 | 970 | 1.020 | 1.666 |
| Gross Profit/Loss - EUR | 198 | -244 | -762 | -1.814 | -1.790 | 63 | 58 | 44 | 900 | 345 |
| Net Profit/Loss - EUR | 164 | -244 | -762 | -1.846 | -1.822 | 32 | 27 | 14 | 900 | 291 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rexona S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.427 | 12.300 | 12.092 | 9.292 | 6.583 | 5.631 | 4.698 | 3.881 | 14.040 | 13.687 |
| Current Assets | 7.056 | 6.707 | 5.831 | 6.489 | 7.070 | 7.795 | 8.458 | 9.329 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.329 | 0 | 0 |
| Cash | 7.056 | 6.707 | 5.831 | 6.489 | 7.070 | 7.795 | 8.458 | 0 | 0 | 0 |
| Shareholders Funds | 19.449 | 19.007 | 17.923 | 15.748 | 13.622 | 13.395 | 13.125 | 13.180 | 14.040 | 14.110 |
| Social Capital | 568 | 562 | 553 | 543 | 532 | 522 | 510 | 512 | 510 | 508 |
| Debts | 34 | 0 | 0 | 32 | 32 | 31 | 30 | 30 | 0 | -423 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Rexona S.r.l.